InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Hunt Anthony, Chairman & CEO. Director active across 4 companies, notably Repligen CORP. Cumulatively, 45 disclosures have been recorded. Breakdown: 1 buy · 4 sells. Total volume traded: €1.4m. History available since 19 May 2021. The latest transaction was filed on 2 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Hunt Anthony
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations45 total
14,083 sharesCommon StockSEC:0001606030-26-000002:0
9,897 shares@ US$124.9719.5% of flowCommon StockSEC:0001193125-26-087591:0
8,170 sharesCommon StockSEC:0001628280-26-012478:0
2,000 sharesCommon StockSEC:0001193125-25-311290:0
1,784 shares@ US$151.015.4% of flowCommon StockSEC:0001193125-25-283092:0
25,000 shares@ US$33.8717.8% of flowCommon StockSEC:0001193125-25-280266:0
20,000 shares@ US$33.8717.1% of flowCommon StockSEC:0001193125-25-201224:0
11,364 sharesCommon StockSEC:0001562180-25-004809:0
2,043 shares@ US$122.662.5% of flowCommon StockSEC:0000950170-25-073387:0
6,876 sharesCommon StockSEC:0001628280-25-014190:0
5,000 shares@ US$33.871.7% of flowCommon StockSEC:0000950170-25-042026:0
10,142 shares@ US$155.3816.7% of flowCommon StockSEC:0000950170-25-031572:0
2,058 sharesCommon StockSEC:0001562180-25-002060:0
2,825 shares@ US$156.544.7% of flowCommon StockSEC:0000950170-25-030051:0
2,380 shares@ US$164.744.1% of flowCommon StockSEC:0000950170-25-026171:0
11,808 shares@ US$33.874.2% of flowCommon StockSEC:0000950170-24-133812:0
24,246 shares@ US$33.878.6% of flowCommon StockSEC:0000950170-24-130266:0
10,000 shares@ US$33.873.4% of flowCommon StockSEC:0000950170-24-105742:0
13,146 shares0Common StockSEC:0000950170-24-103577:0
2,000 shares@ US$124.082.6% of flowCommon StockSEC:0000950170-24-073836:0
Canonical exit: 12 Sept 2024 (T+90)
7,777 sharesCommon StockSEC:0001562180-24-005063:0
4,274 shares@ US$166.367.2% of flowCommon StockSEC:0000950170-24-063594:0
2,000 shares0Common StockSEC:0000950170-24-034204:0
1 shares@ US$16.550.0% of flowCommon StockSEC:0000950170-24-029523:0
2,867 shares@ US$195.725.7% of flowCommon StockSEC:0000950170-24-028016:0
25 of 45 declarations
About Hunt Anthony
Hunt Anthony is Chief Executive Officer. He has 45 filings in total, and across the recent sample of 45 filings, the reported buy and sell amounts are EUR 231087 and EUR 1195908, with filings ranging from 2021-05-20 to 2026-06-12. The most frequent transaction nature is Levée d'options, and the companies mentioned are REPLIGEN CORP, Repligen CORP, 908 Devices Inc. and Biolife Solutions INC.
